PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmenopause
MeSH D008593 - menopause
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002979:Climacteric
0 Companies
0 Drugs
Success rate
D008593: 
Menopause
11 Companies
5 Drugs
$
Success rate
D008594:Premature menopause
65 Companies
25 Drugs
$
Success rate
D017697:Premenopause
0 Companies
0 Drugs
Success rate
D017698:Postmenopause
3 Companies
4 Drugs
$
Success rate
D047648:Perimenopause
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganEstropipate Estropipate  1993-09-23   
Barr PharmaceuticalsEstropipate Estropipate  1996-11-27   
DuchesnayOspemifene Osphena 2022-11-02 2013-02-26   
Duramed PharmaceuticalsEstropipate Estropipate  1999-11-01   
MylanEstropipate Estropipate  1999-08-26   
PfizerBazedoxifene Conbriza  2009-04-17   
Bazedoxifene, Oestrogens conjugated Duavive  2014-12-16   
Estropipate Ogen  1982-01-01   
Pharmacia & UpjohnEstropipate Ogen  1982-01-01   
ShionogiOspemifene Senshio  2015-01-14   
Sun Pharmaceutical IndustriesEstropipate Ortho-est  1991-02-27   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
77%
10/13
Phase 2
65%
13/20
Phase 3
43%
12/28
Approved: 3Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Estrogens conjugated
Duramed Pharmaceuticals
Estrogens conjugated
Pfizer
Bazedoxifene,
Oestrogens conjugated,
Estropipate,
Chlormadinone acetate,
Estrogens conjugated,
Gestapuran,
Depoprovera,
Viviant
Shionogi
Ospemifene
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use